IJ Pharmaceutical Research
Crossref
1. TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
- Dhriti Kaushik
- Ranjana Bhandari
- Anurag Kuhad
2. In silico identification of new inhibitors for βeta-2-glycoprotein I as a major antigen in antiphospholipid antibody syndrome
- Soodeh Mahdian
- Mahboobeh Zarrabi
- Ashraf Moini
- Monireh Movahedi
- Maryam Shahhoseini
3. Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
- Mauri Dobbs Spendlove
- Trenton M. Gibson
- Shaney McCain
- Benjamin C. Stone
- Tristan Gill
- Brett E. Pickett
4. A non‐polar fraction of
<i>Saponaria officinalis</i>
L. acted as a TLR4/MD2 complex antagonist and inhibited TLR4/MyD88 signaling in vitro and in vivo
- Ga‐Ram Yu
- Dong‐Woo Lim
- Wisurumuni Arachchilage Hasitha Maduranga Karunarathne
- Gi‐Young Kim
- Hyuck Kim
- Jai‐Eun Kim
- Won‐Hwan Park